Up a level |
Innes, Hamish, Hamill, Victoria, McDonald, Scott A, Hayes, Peter C, Johnson, Philip ORCID: 0000-0003-1404-0209, Dillon, John F, Bishop, Jen, Yeung, Alan, Went, April, Barclay, Stephen T et al (show 4 more authors)
(2022)
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
AMERICAN JOURNAL OF GASTROENTEROLOGY, 117 (9).
pp. 1454-1461.
Marra, Fiona ORCID: 0000-0003-1326-1149, Boyle, Alison, Peters, Erica, Morris, Judith, Priest, Matthew, Mcdonald, Natasha and Barclay, Stephen T
(2019)
EFFICACY OF 8 WEEKS GLECAPREVIR/PIBRENTASVIR IN ROUTINE CARE OF PATIENTS WITH CIRRHOSIS AND NON GENOTYPE 3 INFECTION.
.
Boyle, Alison, Marra, Fiona ORCID: 0000-0003-1326-1149, Peters, Erica, Datta, Shouren, Ritchie, Trina, Priest, Matthew, Heydtmann, Mathis and Barclay, Stephen T
(2020)
Eight weeks of sofosbuvir/velpatasvir for genotype 3 hepatitis C in previously untreated patients with significant (F2/3) fibrosis.
JOURNAL OF VIRAL HEPATITIS, 27 (4).
pp. 371-375.
Innes, Hamish, Jepsen, Peter, McDonald, Scott, Dillon, John, Hamill, Victoria, Yeung, Alan, Benselin, Jennifer, Went, April, Fraser, Andrew, Bathgate, Andrew et al (show 9 more authors)
(2021)
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection.
JHEP REPORTS, 3 (6).
100384-.
Lampertico, Pietro, Mauss, Stefan, Persico, Marcello, Barclay, Stephen T, Marx, Steven, Lohmann, Kristina, Bondin, Mark, Zhang, ZhenZhen, Marra, Fiona ORCID: 0000-0003-1326-1149, Belperio, Pamela S et al (show 2 more authors)
(2020)
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naive Patients with Compensated Cirrhosis.
ADVANCES IN THERAPY, 37 (9).
pp. 4033-4042.
Lampertico, Pietro, Mauss, Stefan, Persico, Marcello, Barclay, Stephen T, Marx, Steven, Lohmann, Kristina, Bondin, Mark, Zhang, ZhenZhen, Marra, Fiona ORCID: 0000-0003-1326-1149, Belperio, Pamela S et al (show 2 more authors)
(2020)
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naive Patients with Compensated Cirrhosis (vol 37, pg 4033, 2020).
ADVANCES IN THERAPY, 37 (11).
pp. 4755-4756.
Marra, Fiona ORCID: 0000-0003-1326-1149, Boyle, Alison, Govender, Chris, Biggart, Lynne, Sills, Laura, Ritchie, Trina and Barclay, Stephen T
(2019)
USING POINT OF CARE TESTING, SIMPLIFIED ASSESSMENT AND MONITORING AND MULTIDISCIPLINARY INITIATION OF TREATMENT TO ELIMINATE HEPATITIS C IN A COMMUNITY ADDICTIONS CLINIC: RESULTS FROM PHASE 1 OF THE SPRINGBURN MICROELIMINATION PROJECT.
.
Fan, Rong, Papatheodoridis, George, Sun, Jian, Innes, Hamish, Toyoda, Hidenori, Xie, Qing, Mo, Shuyuan, Sypsa, Vana, Guha, Indra Neil, Kumada, Takashi et al (show 32 more authors)
(2020)
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
JOURNAL OF HEPATOLOGY, 73 (6).
pp. 1368-1378.